Kjel Johnson, PharmD

Vice President, Specialty Product Strategy

As Vice President of Specialty Product Strategy, Kjel Johnson is dedicated to understanding the needs of specialty clients, working with them to conceptualize and develop products that solve these needs and their challenges. Prior to CVS Health, Kjel was vice president of business development for Integra Connect, where he developed data-driven value-based programs to optimize quality and cost of specialty care in payor networks. He received his Doctor of Pharmacy degree from the University of Minnesota, where he also completed a research fellowship. Kjel is a fellow of the American College of Clinical Pharmacy and the Academy of Managed Care Pharmacy, is Board Certified in Pharmacotherapy, and was the founder and publisher of Managed Care Oncology.

Cost Management
Latest Research Reveals Cost Savings Opportunities in Cancer Care More
Briefing
Cost Management
New breast cancer cost savings attainable for health plans using Transform Oncology Care More
Briefing
Specialty
Transform Oncology Care helps manage the complex journey, improve the patient experience and support better cancer care. More
Briefing
Care Management
Research CVS Health revealed at ASCO integrates improving oncology outcomes and quality of care while lowering costs. More
Briefing
Care Management
Research being presented at ASCO annual meeting finds innovation, identifying unaddressed challenges can help improve outcomes, lower costs for oncology More
Briefing
Care Management
Transform Oncology Care from CVS Health uses technology and the latest genomic science to solve some of the biggest challenges in oncology management today More
Feature
Care Management
Payors can better manage oncology costs by optimizing therapy regimen selection using evidence-based guidelines directly integrated into our proprietary Novologix platform. More
Video
Specialty
CVS Health uses its integrated model to manage specialty spend across benefits and help positively impact clinical and financial outcomes. More
Briefing